Patents by Inventor Ehsan Khafipour

Ehsan Khafipour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human catestatin induces gut microbiota dysbiosis
    Patent number: 10463712
    Abstract: Treatment with catestatin changes the proportion of two major phyla Bacteroidetes and Firmicutes in the gut microbiota in an opposite manner observed in intestinal disorders like IBD, IBS or non-intestinal disorders like obesity. Specifically, administration of an effective amount of catestatin increased the relative percentage of Bacteroidetes and decreased the relative percentage of Firmicutes in the gut microbiota.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: November 5, 2019
    Inventors: Jean-Eric Ghia, Mohammed Fazle Alam Rabbi, Ehsan Khafipour, Peris Munyaka
  • Human Catestatin Induces Gut Microbiota Dysbiosis
    Publication number: 20180125927
    Abstract: Treatment with catestatin changes the proportion of two major phyla Bacteroidetes and Firmicutes in the gut microbiota in an opposite manner observed in intestinal disorders like IBD, IBS or non-intestinal disorders like obesity. Specifically, administration of an effective amount of catestatin increased the relative percentage of Bacteroidetes and decreased the relative percentage of Firmicutes in the gut microbiota.
    Type: Application
    Filed: April 25, 2016
    Publication date: May 10, 2018
    Inventors: Jean-Eric Ghia, Mohammed Fazle Alam Rabbi, Ehsan Khafipour, Peris Munyaka